Todd Applebaum Talks About Helping the Biotech Industry Bring Crucial Healthcare Innovations to Market – GlobeNewswire

Beverly Hills , Dec. 01, 2021 (GLOBE NEWSWIRE) -- Drawing on his steep experience in business strategy, operations, manufacturing, and supply chain management across the life sciences spectrum, Todd Applebaum talks with Mission Matters about the pharmaceutical, biologics, and medical device industries. In addition to leading Converge Consulting as Founder and CEO, he also provides senior leadership for many of its projects.

Listen to the complete interview of Todd Applebaum with Adam Torres on Mission Matters Innovation Podcast.

What mission matters to you?

Applebaum says quality and value in healthcare are essential. With governments and payers under greater pressure than ever in the wake of the COVID-19 pandemic, quality is being measured as improvements in patient outcomes.

At Converge Consulting, the mission is to help pharmaceutical and biotech manufacturers understand the new environment and focus on patients and patient outcomes as they bring their new technologies and innovative science to market, ultimately improving or even saving lives.

Tell us more about how you started Converge Consulting.

Applebaum has many years of experience in manufacturing, starting with the automotive and high-tech electronics industries and ultimately moving into consulting for the life sciences. He recognized how manufacturing and operations can help companies address customer needs. He eventually led technical operations at a biotech startup developing cell therapy treatments and witnessed the importance of focusing on patient outcomes in producing and delivering these new treatments. This motivated him to found Converge Consulting to help biotech companies of all sizes build strategic advantage through best practices in manufacturing and operations.

What kind of trends do you see now in the biotech Industry?

The healthcare industry is changing dramatically, Applebaum notes, and points to the increased focus on patient outcomes. He sees two trends leading the way:

These trends are working together to focus biopharma companies on the patient, and specifically on improving patient outcomes. Along with innovative science, they must provide new services, including education, monitoring and financial assistance, as well as bundled diagnostics, devices and ancillary materials. Success now depends on building closer operating relationships with and managing more direct integrations between drug manufacturers, distributors, logistics providers, physicians, and patients to ensure patients are identified, enrolled smoothly, stay on treatment, and ultimately realize the benefits.

How is Converge Consulting helping biotech companies grow?

Applebaum says Converge Consulting helps biotech companies, big and small, understand the new landscape of patient outcomes-focused medicine and then to develop and execute the strategies and operating processes necessary to deliver their innovative treatments to patients.

Biotech companies deal with a variety of challenges and risks at each business stage. Converge helps them manage business risk without compromising essential operations.

Whats next for Converge Consulting?

Applebaum believes that, as our knowledge of biology and the genetic origins of disease continues to grow, developing new approaches for treating diseases and critical health conditions will only accelerate. Cost pressure and the risks inherent in drug development will also remain high, requiring pharmaceutical and biotech companies to focus scarce resources on their science. Converge will continue to operate at the intersection of these new scientific breakthroughs and innovation in patient care models, so that clients deliver treatments that ultimately improve patient outcomes.

To learn more, visit Converge Consulting online.

Media Communications

Inquiries: adamtorres@missionmatters.com

Publicist for Adam Torres and Mission Matters Media KISS PR Brand Story PressWire

Brand Publicity Partners KissPR.com

For more details, visit Kisspr.com. KISS PR Digital PR & Marketing powers the Mission Matters Business podcast with brand storytelling. T: 972.437.8942

See more here:
Todd Applebaum Talks About Helping the Biotech Industry Bring Crucial Healthcare Innovations to Market - GlobeNewswire